Search Results

Knowledge-attitude and practice of Anthrax and brucellosis: Implications for zoonotic disease surveillance and control in pastoral communities of Afar and Somali region, Ethiopia.

• Authors : Tschopp R; Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Allschwil, Switzerland.; University of Basel, Switzerland.

Subjects: Anthrax*/Anthrax*/Anthrax*/epidemiology ; Anthrax*/Anthrax*/Anthrax*/prevention & control ; Brucellosis*/Brucellosis*/Brucellosis*/epidemiology

• Source: PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2024 Apr 04; Vol. 18 (4), pp. e0012067. Date of Electronic Publication: 2024 Apr 04 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101291488 Publication Model: eCollection Cited Medium: Internet

Record details

Pathophysiology, Current Therapeutic Options, Vaccine Candidates, and Drug Targets for Human Brucellosis.

• Authors : Pritam M; Amity Institute of Biotechnology, Amity University Uttar Pradesh Lucknow Campus, Uttar Pradesh, India.; National Institute of Allergy and Infectious Diseases (NIAID), NIH, MD, USA.

Subjects: Brucellosis*/Brucellosis*/Brucellosis*/drug therapy ; Brucellosis*/Brucellosis*/Brucellosis*/prevention & control ; Brucellosis*/Brucellosis*/Brucellosis*/diagnosis

• Source: Current molecular pharmacology [Curr Mol Pharmacol] 2024; Vol. 17 (1), pp. e130723218680.Publisher: Bentham Science Publishers Country of Publication: United Arab Emirates NLM ID: 101467997 Publication Model: Print Cited Medium: Internet

Record details

A systematic analysis of and recommendations for public health events involving brucellosis from 2006 to 2019 in China.

• Authors : Liu Z; National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.; Wang M

Subjects: Brucellosis*/Brucellosis*/Brucellosis*/epidemiology ; Brucellosis*/Brucellosis*/Brucellosis*/prevention & control ; Vaccines*

• Source: Annals of medicine [Ann Med] 2022 Dec; Vol. 54 (1), pp. 1859-1866.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8906388 Publication Model: Print Cited Medium: Internet ISSN: 1365-2060

Record details

Immune complex-mediated glomerulonephritis post COVID-19 vaccination in a patient with concomitant Brucellosis.

• Authors : Al Bakr S; From the Internal Medicine and Rheumatology, Prince Sultan Military Medical City, Riyadh, Kingdom of Saudi Arabia.; Alaithan MA

Subjects: Brucellosis*/Brucellosis*/Brucellosis*/complications ; Brucellosis*/Brucellosis*/Brucellosis*/drug therapy ; COVID-19*/COVID-19*/COVID-19*/complications

• Source: Saudi medical journal [Saudi Med J] 2022 May; Vol. 43 (5), pp. 522-525.Publisher: Medical Services Department, Saudi Arabian Armed Forces, Ministry Of Defence And Aviation Country of Publication: Saudi Arabia NLM ID: 7909441

Record details

Design of multi-epitope vaccine candidate against Brucella type IV secretion system (T4SS).

• Authors : Yin Z; The First Affiliated Hospital of Xinjiang Medical University, Xinjiang, China.; Li M

Subjects: Brucella* ; Vaccines* ; Brucellosis*/Brucellosis*/Brucellosis*/prevention & control

• Source: PloS one [PLoS One] 2023 Aug 10; Vol. 18 (8), pp. e0286358. Date of Electronic Publication: 2023 Aug 10 (Print Publication: 2023).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

Bioinformatics analysis of Omp19 and Omp25 proteins for designing multi-epitope vaccines against Brucella.

• Authors : Shi D; Clinical Laboratory Center, Traditional Chinese Medicine Hospital Affiliated to Xinjiang Medical University, Urumqi, P.R. China.; Chen Y

Subjects: Brucella* ; Brucellosis* ; Vaccines*

• Source: Medicine [Medicine (Baltimore)] 2023 Mar 17; Vol. 102 (11), pp. e33182.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN:

Record details

Multi-Epitope Vaccine Candidates Associated with Mannosylated Chitosan and LPS Conjugated Chitosan Nanoparticles Against Brucella Infection.

• Authors : Sadeghi Z; Department of Molecular Biology, Pasteur Institute of Iran, Tehran, Iran.; Fasihi-Ramandi M

Subjects: Chitosan* ; Brucella melitensis* ; Brucellosis*/Brucellosis*/Brucellosis*/prevention & control

• Source: Journal of pharmaceutical sciences [J Pharm Sci] 2023 Apr; Vol. 112 (4), pp. 991-999. Date of Electronic Publication: 2023 Jan 06.Publisher: Elsevier Country of Publication: United States NLM ID: 2985195R Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Pathogenesis of Brucella ovis in pregnant mice and protection induced by the candidate vaccine strain B. Ovis ΔabcBA.

• Authors : Braz HMB; Departamento de Clínica e Cirurgia Veterinárias, Escola de Veterinária, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.; Silva MF

Subjects: Brucella Vaccine* ; Brucella ovis* ; Brucellosis*

• Source: Vaccine [Vaccine] 2022 Jul 30; Vol. 40 (32), pp. 4617-4624. Date of Electronic Publication: 2022 Jun 22.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Agricola

Record details

Agricola

Record details